# 2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects

> **NCT01673451** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 24 (actual)

## Conditions studied

- CNS

## Interventions

- **DRUG:** E2006
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT01673451
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673451, "2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01673451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*